Dyne Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 17.54 M | $343.09 M | 523.66% | 12.37% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 13.89 M | $271.60 M | -5.82% | 9.79% |
| VANGUARD GROUP INC | 01/29/2026 | 11.22 M | $219.38 M | 14.91% | 7.91% |
| BLACKROCK, INC. | 02/12/2026 | 11.19 M | $218.89 M | 16.15% | 7.89% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 02/13/2026 | 9.13 M | $178.59 M | 0.00% | 6.44% |
| STATE STREET CORP | 02/13/2026 | 6.69 M | $130.91 M | 27.02% | 4.72% |
| FMR LLC | 02/17/2026 | 6.57 M | $128.51 M | 21.62% | 4.63% |
| FCPM III SERVICES B.V. | 02/17/2026 | 5.46 M | $106.85 M | 0.00% | 3.85% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 5.17 M | $101.16 M | 45.53% | 3.65% |
| ORBIS ALLAN GRAY LTD | 02/17/2026 | 4.80 M | $93.93 M | 100.00% | 3.39% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 4.62 M | $90.27 M | 0.00% | 3.25% |
| JPMORGAN CHASE & CO | 02/11/2026 | 3.55 M | $69.44 M | 5.49% | 2.50% |
| SIREN, L.L.C. | 02/13/2026 | 3.50 M | $68.52 M | -25.93% | 2.47% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 3.48 M | $68.05 M | 543.72% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.26 M | $63.84 M | 13.80% | 2.30% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 3.25 M | $63.56 M | 6.06% | 2.29% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 3.15 M | $61.67 M | 16.00% | 2.22% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 2.65 M | $51.83 M | 32.50% | 1.87% |
| VIVO CAPITAL, LLC | 02/13/2026 | 2.61 M | $51.15 M | 0.00% | 1.84% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 2.32 M | $45.45 M | 66.21% | 1.64% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.28 M | $44.66 M | 20.15% | 1.61% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 2.25 M | $44.09 M | 128.66% | 1.59% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 2.20 M | $43.07 M | -4.84% | 1.55% |
| VR ADVISER, LLC | 02/17/2026 | 2.17 M | $42.52 M | 0.00% | 1.53% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.01 M | $39.25 M | 43.48% | 1.42% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.79 M | $34.99 M | -33.12% | 1.26% |
| SAMLYN CAPITAL, LLC | 02/17/2026 | 1.49 M | $29.20 M | 100.00% | 1.05% |
| BRAIDWELL LP | 02/17/2026 | 1.48 M | $28.92 M | -45.86% | 1.04% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 1.47 M | $28.80 M | 16.59% | 1.04% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.41 M | $27.49 M | -2.83% | 0.99% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.27 M | $24.82 M | 139.74% | 0.89% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 1.25 M | $24.45 M | -47.92% | 0.88% |
| MORGAN STANLEY | 02/13/2026 | 1.21 M | $23.74 M | -14.48% | 0.86% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.17 M | $22.92 M | -65.68% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.15 M | $22.52 M | 14.31% | 0.81% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/17/2026 | 1.14 M | $22.28 M | 25.02% | 0.80% |
| ABRDN PLC | 01/16/2026 | 1.11 M | $21.68 M | 99.04% | 0.78% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.09 M | $21.36 M | 5.26% | 0.77% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.06 M | $20.68 M | 26.78% | 0.75% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 912.96 K | $17.86 M | 10.79% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 904.39 K | $17.69 M | 118.48% | 0.64% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 882.92 K | $17.27 M | 16.00% | 0.62% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 835.20 K | $16.34 M | 75.98% | 0.59% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 813.45 K | $15.91 M | 100.00% | 0.57% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 700.65 K | $13.70 M | -10.85% | 0.49% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 680.31 K | $13.31 M | 100.00% | 0.48% |
| MARSHALL WACE, LLP | 02/13/2026 | 676.98 K | $13.24 M | -77.53% | 0.48% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/17/2026 | 649.69 K | $12.71 M | 100.00% | 0.46% |
| NUVEEN, LLC | 02/12/2026 | 621.31 K | $12.15 M | 80.14% | 0.44% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 530.34 K | $10.37 M | 589.54% | 0.37% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dyne Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 307 institutional investors and hedge funds held shares of Dyne Therapeutics Inc. The most heavily invested institutionals were:
abrdn plc: 1.43 M
Fiera Capital Corp: 1.38 M
DIMENSIONAL FUND ADVISORS LP: 951,589
VANGUARD FIDUCIARY TRUST CO: 947,438
Nuveen, LLC: 718,333
TD ASSET MANAGEMENT INC: 529,312
125.48% of Dyne Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 190.03 M shares in the last 24 months. This purchase volume represents approximately $3.36 B in transactions.